These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 17546230

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
    Thapa S, Hollander J, Linehan M, Cox-Singh J, Bista MB, Thakur GD, Davis WA, Davis TM.
    Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
    Fryauff DJ, Leksana B, Masbar S, Wiady I, Sismadi P, Susanti AI, Nagesha HS, Syafruddin, Atmosoedjono S, Bangs MJ, Baird JK.
    Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
    Thriemer K, Haque R, Wagatsuma Y, Salam MA, Akther S, Attlmayr B, Fukuda M, Schaecher K, Miller RS, Noedl H.
    Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M.
    JAMA; 2007 May 23; 297(20):2201-9. PubMed ID: 17519409
    [Abstract] [Full Text] [Related]

  • 53. Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan.
    Elamin SB, Malik el-FM, Ahmed el-DS, Elabadil EK, Mohamad TA.
    East Mediterr Health J; 2007 May 23; 13(1):25-34. PubMed ID: 17546902
    [Abstract] [Full Text] [Related]

  • 54. [Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].
    Montoya P, Tobón A, Blair S, Carmona J, Maestre A.
    Biomedica; 2007 Jun 23; 27(2):204-15. PubMed ID: 17713631
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
    Djimdé AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK.
    Am J Trop Med Hyg; 2008 Mar 23; 78(3):455-61. PubMed ID: 18337343
    [Abstract] [Full Text] [Related]

  • 58. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Aubouy A, Migot-Nabias F, Deloron P.
    Infect Genet Evol; 2007 Mar 23; 7(2):147-54. PubMed ID: 16890498
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.